Starpharma Holdings Ltd SPHRY:OTCQX

RT Quote | Exchange | USD
Last | 02/26/21 EST
16.56quote price arrow down-0.44 (-2.59%)
Volume
885
52 week range
3.67 - 19.87

...

Loading . . .

KEY STATS

  • Open17.04
  • Day High17.04
  • Day Low16.50
  • Prev Close17.00
  • 52 Week High19.87
  • 52 Week High Date02/17/21
  • 52 Week Low3.67
  • 52 Week Low Date03/24/20
  • Market Cap666.14M
  • Shares Out37.26M
  • 10 Day Average Volume12,342.73
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • 1 Year % Change126.85

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Starpharma Holdings Ltd News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Starpharma Holdings Limited is engaged in development of dendrimer products for pharmaceutical, life science and other applications. The Company utilizes dendrimers, which is a type of synthetic nanoscale polymer that is regular in size and structure and suited to pharmaceutical and medical uses. The Company’s development programs, including VivaGel portfolio and DEP drug delivery. The Company’s DEP drug delivery, which includes DEP docetaxel, DEP cabazitaxel, DEP irinotecan...
Robert Thomas
Non-Executive Chairman
Jacinth Fairley
Chief Executive Officer
Nigel Baade CPA
Chief Financial Officer
David Owen Ph.D.
Vice President
Jeremy Paull Ph.D.
Vice President
Address
4-6 Southampton Crescent, Abbotsford
Melbourne, VIC
3067
Australia